ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden

ASXL1突变在JAK2V617F等位基因负荷低的原发性骨髓纤维化患者中预后不良，但在等位基因负荷高的患者中则无此预后。